Anneli Savinainen
Vice President, Head of Preclinical Development @Mariana Oncology
Signup · Get unlimited contacts
WORK HISTORY
Vice President, Head of Preclinical Development @Mariana Oncology
Watertown, MA, US
Executive leader overseeing integrated Preclinical Development functions including DMPK/ADME, Pharmacology, Preclinical Imaging and Toxicology.*Advanced precision radioligand therapies from discovery through IND and early clinical development, delivering multiple successful IND submissions.*Built, led, and mentored high‑performing cross‑functional teams across scientific disciplines and leadership levels.*Defined and executed regulatory‑enabling nonclinical strategies; authored and reviewed nonclinical sections of INDs and IBs and supported global regulatory interactions.*Directed preclinical timelines, budgets, and global CRO partnerships to ensure high‑quality, compliant, and efficient execution.*Member of the Research executive leadership team, partnering cross‑functionally to guide portfolio and development strategy.*Served as IACUC Chair and liaison to the Global Animal Welfare Committee, accountable for animal welfare compliance across internal and outsourced studies.
EDUCATION
University of Arizona
Pharmacokinetics and Toxicokinetics for the Industrial Scientist
Northeastern University
Master Certificate, Clinical Trial and Project Management
Northeastern University
Master's degree, Pharmacology
SKILLS
ABOUT ANNELI SAVINAINEN
As an accomplished executive in the biopharmaceutical industry, with comprehensive expertise in preclinical research and development, I am committed to advancing breakthrough therapies and driving novel treatments from discovery through IND-enabling studies into clinical development. With extensive knowledge in pharmacology, toxicology, and pharmacokinetics, I collaborate cross-functionally with Discovery, CMC, Clinical, and Regulatory teams to navigate complex development pathways and bring safe, effective therapies to patients.I passionate about contribute to the development of life-changing drugs while upholding the highest standards of data integrity and quality. I bring natural strengths in organization, efficiency, and timely execution, and I thrive in a fast-paced, high-pressure environment where science and strategy align to make a real impact.Specialties: drug development, pharmacology, complex animal models, toxicology, pharmacokinetics, translational sciences, data analysis, study design, documentation, GLP, imaging, leadership, project management, CRO management, regulatory, IND enabling studies, IND submission, regulatory interactions
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.